Sodium Cyanide → Citalopram
Reaction equation
N[C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[C:7]([CH2:18][CH2:19][CH2:20][N:21]([CH3:23])[CH3:22])([C:11]1[CH:16]=[CH:15][C:14]([F:17])=[CH:13][CH:12]=1)[O:6][CH2:5]2.N([O-])=O.[Na+].C([O-])([O-])=O.[Na+].[Na+].[C:34]([Cu])#[N:35].[C-]#N.[Na+]>O.OS(O)(=O)=O.C1(C)C=CC=CC=1>[CH3:22][N:21]([CH3:23])[CH2:20][CH2:19][CH2:18][C:7]1([C:11]2[CH:16]=[CH:15][C:14]([F:17])=[CH:13][CH:12]=2)[C:8]2[C:4](=[CH:3][C:2]([C:34]#[N:35])=[CH:10][CH:9]=2)[CH2:5][O:6]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 2.5 °C
Procedure
5-Amino-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran (18 g, 0.06 mole) is dissolved in water (100 ml) and H2SO4(8 ml). NaNO2(4.1 g, 0.06 mole) is dissolved in water (20 ml) and added dropwise below 5° C. The diazotised solution is stirred for 0.5 hour at 0-5° C. pH is brought to 6.5 by adding a saturated solution of Na2CO3. This solution is added to a mixture of water (100 ml) and toluene (120 ml) containing CuCN(6 g, 0.067 mole) and NaCN (10 g, 0.2 mole) at 50-60C°. Stirring is continued for 0.5 hour. The phases are separated and the aqueous phase is further extracted with toluene (100 ml). The combined organic phase is washed with NaCN(10% aq., 2×50 ml). The solvent is removed in vacuo and the residue is chromatograhed on silica gel (ethyl acetate: n-heptane: triethylamine; 85:10:5 ) to give the title compound (6 g, 32%) as an oil.
Workup
- additionadded dropwise below 5° C
- stirringStirring
- waitis continued for 0.5 hour
- customThe phases are separated
- extractionthe aqueous phase is further extracted with toluene (100 ml)
- washThe combined organic phase is washed with NaCN(10% aq., 2×50 ml)
- customThe solvent is removed in vacuo
Sources & evidence
- ORD record
- ord-7cc65714ed4547b1a3d15cfabd1c714c
- Source dataset
- uspto-grants-2001_07
- Patent number
- US06258842B1
Reaction notes
Loading…